302 related articles for article (PubMed ID: 18804177)
1. Addressing the frustrations of finding new effective antibacterials to combat drug resistant bacteria.
Fernandes P; Pizza M
Curr Opin Microbiol; 2008 Oct; 11(5):385-6. PubMed ID: 18804177
[No Abstract] [Full Text] [Related]
2. Antimicrobial resistance: no action today, no cure tomorrow.
Sharma A
Indian J Med Microbiol; 2011; 29(2):91-2. PubMed ID: 21654100
[No Abstract] [Full Text] [Related]
3. Development of new antibacterials: a laudable aim, but what is the value?
Tillotson GS
Clin Infect Dis; 2010 Sep; 51(6):752-3; author reply 754-5. PubMed ID: 20731567
[No Abstract] [Full Text] [Related]
4. Multi-targeting by monotherapeutic antibacterials.
Silver LL
Nat Rev Drug Discov; 2007 Jan; 6(1):41-55. PubMed ID: 17159922
[TBL] [Abstract][Full Text] [Related]
5. Coping with antibiotic resistance: the impending crisis.
Gould IM
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S1-2. PubMed ID: 21129626
[TBL] [Abstract][Full Text] [Related]
6. Questions about the 10 x '20 Initiative.
Outterson K; Powers JH; Gould IM; Kesselheim AS
Clin Infect Dis; 2010 Sep; 51(6):751-2; author reply 754-5. PubMed ID: 20731566
[No Abstract] [Full Text] [Related]
7. Novel target sites in bacteria for overcoming antibiotic resistance.
Black MT; Hodgson J
Adv Drug Deliv Rev; 2005 Jul; 57(10):1528-38. PubMed ID: 15949866
[TBL] [Abstract][Full Text] [Related]
8. Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative.
Burgess DS; Slain D; Mohr J; Wong-Beringer A; Destache C; Suda K
Clin Infect Dis; 2010 Sep; 51(6):753; author reply 754-5. PubMed ID: 20731568
[No Abstract] [Full Text] [Related]
9. Antibacterial resistance: is there a way out of the woods?
Marra A
Future Microbiol; 2011 Jul; 6(7):707-9. PubMed ID: 21797683
[No Abstract] [Full Text] [Related]
10. The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.
Infectious Diseases Society of America
Clin Infect Dis; 2010 Apr; 50(8):1081-3. PubMed ID: 20214473
[TBL] [Abstract][Full Text] [Related]
11. The antibiotic resistome: challenge and opportunity for therapeutic intervention.
MartÃnez JL
Future Med Chem; 2012 Mar; 4(3):347-59. PubMed ID: 22393941
[TBL] [Abstract][Full Text] [Related]
12. What's new on the antimicrobial horizon?
Song JH
Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521
[TBL] [Abstract][Full Text] [Related]
13. The antibiotic R&D pipeline: an update.
Jabes D
Curr Opin Microbiol; 2011 Oct; 14(5):564-9. PubMed ID: 21873107
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance is ancient: implications for drug discovery.
Wright GD; Poinar H
Trends Microbiol; 2012 Apr; 20(4):157-9. PubMed ID: 22284896
[TBL] [Abstract][Full Text] [Related]
15. 2012 and beyond: potential for the start of a second pre-antibiotic era?
Appelbaum PC
J Antimicrob Chemother; 2012 Sep; 67(9):2062-8. PubMed ID: 22687888
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic bacteria: how to get them back into the line of fire?
Keck W; Hubschwerlen C
Curr Opin Investig Drugs; 2005 Feb; 6(2):139-40. PubMed ID: 15751735
[No Abstract] [Full Text] [Related]
17. The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time?
Vicente M; Hodgson J; Massidda O; Tonjum T; Henriques-Normark B; Ron EZ
FEMS Microbiol Rev; 2006 Nov; 30(6):841-52. PubMed ID: 17064283
[TBL] [Abstract][Full Text] [Related]
18. Discovery research: the scientific challenge of finding new antibiotics.
Livermore DM;
J Antimicrob Chemother; 2011 Sep; 66(9):1941-4. PubMed ID: 21700626
[TBL] [Abstract][Full Text] [Related]
19. Whither antibacterial drug discovery?
Projan SJ
Drug Discov Today; 2008 Apr; 13(7-8):279-80. PubMed ID: 18405838
[No Abstract] [Full Text] [Related]
20. Addressing the problem of increased antibiotic resistance.
Kelly J
Prof Nurse; 2001 Sep; 17(1):56-9. PubMed ID: 12030151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
